Journey Medical Corporation logo

Journey Medical Corporation

NASDAQ:DERM

Overview | Financials
Company Name Journey Medical Corporation
Symbol DERM
Currency USD
Price 3.73
Market Cap 77,919,458
Dividend Yield 0%
52-week-range 2.85 - 6.89
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Claude Maraoui
Website https://journeymedicalcorp.com

An error occurred while fetching data.

About Journey Medical Corporation

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox,

Related Stocks

BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp.

BCTX

0.39 USD

Viracta Therapeutics, Inc. logo

Viracta Therapeutics, Inc.

VIRX

0.17 USD

Augmedix, Inc. logo

Augmedix, Inc.

AUGX

2.345 USD

Centogene N.V. logo

Centogene N.V.

CNTG

0.325 USD

Eyenovia, Inc. logo

Eyenovia, Inc.

EYEN

0.086 USD

Galectin Therapeutics Inc. logo

Galectin Therapeutics Inc.

GALT

1.15 USD

Minerva Surgical, Inc. logo

Minerva Surgical, Inc.

UTRS

0 USD

Financials

Numbers are in millions USD

Numbers are in millions USD